Table 3.
Regression models assessing the risk of multi-drug resistant bacteria positivity.
| Variable | Odds Ratio (95%CI) | |||||
|---|---|---|---|---|---|---|
| Bacteria | Any MDR bacteria* | CRE | VRE | MRSA | CR-ACIN | C. difficile |
| Female | 0.68 (0.63 to 0.74) | 0.65 (0.54 to 0.78) | 0.79 (0.65 to 0.96) | 0.6 (0.52 to 0.68) | 0.48 (0.41 to 0.56) | 0.8 (0.7 to 0.92) |
| Residence (reference: Israeli patients) | ||||||
| Palestinian | 8.0 (6.3 to 10.1) | 6.8 (3.8 to 12.1) | 7.3 (3.8 to 13.7) | 5.1 (3.4 to 7.6) | 13.5 (8.4 to 21.7) | 5.7 (3.8 to 8.5) |
| Foreign tourists | 2.3 (1.6 to 3.3) | 4.9 (2.4 to 10.1) | 2.5 (1.2 to 5.1) | 0.85 (0.45 to 1.65) | 2.7 (1.4 to 5.4) | 1.1 (0.7 to 1.9) |
| Age (reference: age up to 18) | ||||||
| 18 to 40 | 1.05 (0.9 to 1.2) | 1.9 (1.2 to 2.8) | 2.3 (1.5 to 3.6) | 0.8 (0.63 to 1.0) | 3.5 (2.5 to 5.1) | 0.9 (0.7 to 1.1) |
| 40 to 65 | 3.2 (2.8 to 3.6) | 7.6 (5.3 to 11.1) | 10.9 (7.2 to 16.4) | 2.1 (1.7 to 2.6) | 9.5 (6.7 to 13.3) | 3 (2.4 to 3.8) |
| 65 to 80 | 5.9 (5.2 to 6.7) | 19 (13.1 to 27.4) | 16.6 (11 to 25.2) | 4.0 (3.2 to 4.9) | 11.6 (8.3 to 16.4) | 6.4 (5.2 to 8) |
| above 80 | 9.1 (7.9 to 10.4) | 26 (17.8 to 38.1) | 18.2 (11.8 to 28.2) | 4.6 (3.7 to 5.8) | 15.8 (11 to 22.8) | 11.5 (9.3 to 14.5) |
MDR, multi-drug resistant; CRE, carbapenem resistant Enterobacteriaceae; VRE, vancomycin resistant Enterococci; CR-ACIN, carbapenem resistant Acinetobacter baumannii.
*The model was also controlled for hospitalization in the prior six months.